血液滤过治疗重症急性胰腺炎的研究进展

Advance in hemofiltrafion for severe acute pancreatitis

重症急性胰腺炎(SAP)的治疗是临床上的一个难题,血液滤过应用于SAP的治疗已有20余年的历史,血液滤过能清除SAP患者血液中过度激活的炎症因子,阻断全身炎症反应综合征,同时维持水电解质平衡,在SAP的治疗中发挥着越来越重要的作用。同时血液滤过在SAP治疗中的应用也存在一些争议和需进一步研究的问题,本文总结了近年来关于血液滤过治疗SAP的最新进展,以便使其更好地被应用于临床。

The treatment of severe acute pancreatitis (SAP)is a difficult clinical problem.Hemofiltration has been used in the treatment of SAP for more than 20 years.Hemofiltration can clear excessively activated inflammatory factors of blood and block systemic inflammatory response syndrome (SIRS),while maintaining waterelectrolyte balance.It plays an more and more important role in the treatment of SAP.At the same time,the application of hemofiltration in the treatment of SAP is also controversial and requires further study.This paper will summarize recent advances in hemofiltration for SAP so as to achieve better application of hemofihration in clinical practice.